Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) for innovative precision
therapies. This review examines the current state of
targeted therapies for intracranial
Beylerli, Ozal,
Shi, Huaizhang,
Begliarzade, Sema,
Shumadalova, Alina,
Ilyasova, Tatiana,
Sufianov, Albert (2024) metastases, offering valuable insights into underlying mechanisms and potential therapeutic
targets, such as therapeutic
targets and non-invasive diagnostic/prognostic biomarker tools. © 2024, The Author(s).
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) effectively
target various structures within the central nervous system (CNS). MiRNA-based
therapy stands out
of global death. The purpose of our bioinformatics analysis was to detect viable pathophysiological
targetsBEYLERLI, OZAL,
BEERAKA, NARASIMHA M.,
GAREEV, ILGIZ,
PAVLOV, VALENTIN,
YANG, GUANG,
LIANG, YANCHAO,
ALIEV, GJUMRAKCH (2020) single-stranded RNA molecules that can influence post-transcriptional regulation by controlling
target. Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogeneity and resistance to
therapy. Modern
for comprehensive clinical trials to establish the efficacy of polyphenol-based
therapies targeting nc
Begliarzade, Sema,
Sufianov, Albert,
Ilyasova, Tatiana,
Shumadalova, Alina,
Sufianov, Rinat,
Beylerli, Ozal,
Yan, Zhongrui (2024) for early CC detection and hold potential as therapeutic
targets for intervention. By delving
Beylerli, Ozal,
Ju, Jiaming,
Beilerli, Aferin,
Gareev, Ilgiz,
Shumadalova, Alina,
Ilyasova, Tatiana,
Bai, Yunlong,
Yang, Baofeng (2023) drug
therapy for AF patients is often ineffective and may have adverse effects. Radiofrequency ablation